Results 1 - 10 for Antiplatelet drug

Drug Class Review on Newer Antiplatelet Agents
TABLE OF CONTENTS INTRODUCTION ..... 5 Scope and Key Questions ...
http://www.ohsu.edu/ohsuedu/research/policycenter/customcf/derp/product/AP_Final_Report_Update%2015.pdf
open  pop

Daiichi Sankyo, Lilly Submit New Drug Application for Investigational ...
Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration If Approved for Marketing in the United ...
http://files.shareholder.com/downloads/LLY/0x0x154857/c7675063-c97d-40fe-9437-407f15687f69/LLY_News_2008_1_4_Product.pdf
open  pop

Daiichi Sankyo, Lilly Submit New Drug Application for Investigational ...
... that on Wednesday, December 26, 2007, they submitted a New Drug Application (NDA) for prasugrel to the U.S. Food and Drug Administration (FDA). Prasugrel is an oral antiplatelet ...
http://www.daiichisankyo.com/4less/cgi-bin/cs4view_obj.php/b_newsrelease_n1_eng/410/080107v1-e.pdf
open  pop

Drug Class Review
Preliminary Scan Report Drug Effectiveness Review Project Appendix A. Abstracts of potentially relevant new trials of Newer Antiplatelet Agents Bartorelli, A. L., C. Tamburino, et al ...
http://www.rx.wa.gov/documents/ap_scan.pdf
open  pop

FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative ...
... Corporate Communications Department Telephone: +81-3-6225-1126 http://www.daiichisankyo.com/ FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug ...
http://www.daiichisankyo.com/4less/cgi-bin/cs4view_obj.php/b_newsrelease_n1_eng/521/080624v1-e.pdf
open  pop

Antiplatelet drugs reviewed - Consumer Reports Health
Treating Heart Disease, Heart Attack, and Stroke: The Antiplatelet Drugs Comparing Effectiveness, Safety, and Price ®
http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/Antiplatelets-FINAL.pdf
open  pop

Daiichi Sankyo, Lilly Submit Marketing Authorization Application for ...
... 1086 (cell) Shigemici Kondo Daiichi Sankyo (Tokyo) +81-3-6225-1126 (office) Daiichi Sankyo, Lilly Submit Marketing Authorization Application for Investigational Oral Antiplatelet Drug ...
http://www.dsi.com/news/pdfs/EMEA_SUBMIT_FINAL_APPROVED.pdf
open  pop

Your Antiplatelet Medication:
Take All Medications Instructed After you leave the hospital, your cardiologist will instruct you to take a daily dose of aspirin and another antiplatelet drug such as Plavix®
http://www.xiencev.com/documents/anticlotting_medication_brochure.pdf
open  pop

The Antiplatelet Activity of Aspirin
A once daily aspirin antiplatelet regimen is effective because: a) very high doses of aspirin are used b) the drug accumulates intracellularly from where it is gradually released c ...
http://www.mcppnet.org/publications/ISSUE03-5.pdf
open  pop

EARLY vs. DELAYED PROVISIONAL UTILIZATION OF ANTI-PLATELET DRUG
... ACS study (Early Glycoprotien IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes) aimed to clarify the best strategy for eptifibatide use, an antiplatelet drug ...
http://www.acc.org/media/acc_scientific_session_09/press/monday/ACC09Newby_915.pdf
open  pop

Featured Results: